. 2021 Feb 27:1–36. doi: 10.1080/08830185.2021.1883600
© 2021 Taylor & Francis Group, LLC
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
Figure 7.
Different types of immunotherapies for prevention of COVID 19.